Skip to main content
OpenTrials
Completed

NCT Number: NCT01669057

Study on Clinical Prognosis, Risk Factors and Genetic Basis of Congenital Heart Disease

The objective of this study is to investigate the effect of parental peri-natal environmental risk factors and genetic factors on the development of Congenital Heart Disease (CHD). Our hypothesis is that the distributions of some environmental and genetic risk factors significantly differ between neonates with and without CHD.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 3 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Children Hospital of Fudan University

Shanghai, Shanghai Municipality, 201102, China

About this study

Congenital heart defect (CHD) is one of birth defects in the structure of the heart and/or great vessels. Many types of heart defects exist, most of which either obstruct blood flow in the heart or vessels near it, or cause blood to flow through the heart in an abnormal pattern. Heart defects are the leading cause of birth defect-related infant deaths. So far people recognize that the causes of CHD are the conjunct effect of environment and genetic factors, both of which remain unclear. The current stud aims at investigating all the possible perinatal parental environmental risk factors and underlying genetic factors to CHD, including DNA variation and methylations. A hospital-based 1:1 matched case control study is conducted. Subjects were recruited through neonatal screening program, which includes a clinical symptom screening followed by a cardiac ultrasound diagnosis for those with at least one clinical indicator. The blood sample of participant will be collected and the parents of subjects will be interviewed to completed a questionnaire including general information and possible risk factors to CHD.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

case group

Inclusion criteria

  • Han ethnic
  • 0~3 years old
  • screened by 7 indicator, diagnosed by ultrasound

Exclusion criteria

  • with other brith defects
  • with Patent Ductus Arteriosus (PDA) and Patent Foramen Ovale (PFO)

Control group

Inclusion criteria

  • Han ethnic
  • 0~3 years old
  • without any of 7 screen indicator , without CHD heart palpitations and other complaints about heart disease, born in the same hospital with cases

Exclusion criteria

With other birth defects

Treatment and study plan

Primary outcomes

  1. genome-wide DNA SNPs and methylations

    Time frame: delivery

    DNA sample from neonate blood

  2. perinatal supplements and drug using

    Time frame: three months before pregnancy till delivery

    questionnaire including supplements and drug using for mother

Secondary outcomes

  1. Life risk factors of mother

    Time frame: three months before pregnancy till delivery

    smoking, drinking, health, family history

  2. Life risk factors of father

    Time frame: three months before pregnancy till delivery

    smoking, drinking, health, family history

  3. gestational weeks

    Time frame: delivery

  4. birth weight

    Time frame: delivery

Sponsors and collaborators

Lead sponsor

Children's Hospital of Fudan University

Other

Collaborators

  • Changzhou Maternal and Child Care Hospital
  • Kunshan City Maternal and Child Health
  • Maternal and Child Health Hospital of Taian
  • Maternal and Child Health Hospital of Wuxi
  • Maternal and Child Health Hospital, Jiading District
  • Minhang Maternal and Children Health Care Hospital
  • Ningbo Women & Children's Hospital
  • The First Affiliated Hospital of Xiamen University

Registry information

Official study title

Case-control Study on Environmental and Genetic Factors of Congenital Heart Disease

Acronym: SCPRFGBCHD

Important dates

Study start
2011
Study completion
2014
First posted
Aug 20, 2012
Registry last updated
Mar 11, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.